Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Breast Neoplasms × Oxycodone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Cancer Pain 8 Neoplasms 5 Pain 4 Prostatic Neoplasms 1 Opioid-Induced Constipation 1 Inflammation 1 Endobronchial Metastases 1 Chronic Pain 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Acute Pain 1

Interventions

Letrozole 16 Docetaxel 11 Anastrozole 11 exemestane 10 Cyclophosphamide 9 Zoledronic Acid 8 Tamoxifen 8 Trastuzumab 7 Paclitaxel 7 Capecitabine 7 pegfilgrastim 6 Saline Solution 6 Fulvestrant 6 liposomal doxorubicin 5 Dexmedetomidine 5 Bupivacaine 5 Bevacizumab 5 Tranexamic Acid 4 Sodium Chloride 4 Filgrastim 4 Epirubicin 4 trastuzumab deruxtecan 3 technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 3 ribociclib 3 pertuzumab 3 palbociclib 3 eribulin 3 abemaciclib 3 Standard of Care 3 Sevoflurane 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04726878 2021-11-09

ESP in Breast Surgery Due to Cancer

Medical University of Lublin

Phase 4 Completed

Breast Neoplasms, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡